Human immunodeficiency virus knowledge and stigma among medical students in Egypt: a national cross-sectional study Authors: Yusof Mohamed Omar, Mohab Alsaid Saad, Olga Maria Eltarazy, Tasneem Deibes, Amr Ashraf Kamel, Mahmoud Yehia Basha, Mariam Mohamed Elsaeed, Esraa M Soliman, Sarah Youssef Atta, Abdel-Hady El-Gilany, Mohamed Fathi Published: 2026 ABSTRACT AbstractObjectivesTo assess HIV knowledge, stigma and perceived adequacy of HIV curricular coverage among medical students in Egypt and to identify factors associated with HIV stigma.DesignAn online-based cross-sectional study.SettingMedical schools across Egypt. Data were collected in August 2025 using a bilingual (Arabic/English) online questionnaire using convenience sampling.ParticipantsFirst- through fifth-year students enrolled in Egyptian medical schools.Primary and secondary outcome measuresHIV knowledge was assessed using the Brief HIV Knowledge Questionnaire (HIV-KQ-18); HIV-related stigma was assessed using the Healthcare Providers HIV/AIDS Stigma Scale (HPASS) and perceived adequacy of HIV curricular coverage.ResultsA total of 1503 students participated (mean age 20.6 years; 57.4% female), half of whom (48.9%) rated curricular coverage of stigma and psychosocial aspects of HIV as inadequate. The mean HIV-KQ-18 score was 8.96/18 (SD 4.26). Only 39.9% recognised that HIV cannot be transmitted through kissing, 47% believed washing after sex is protective and just 41.3% knew that not all infants born to mothers with HIV will have AIDS. The mean HPASS score was 60.1/108 (SD 17.6). Most students (76.8%) worried about contracting HIV from patients, 52% believed patients acquired HIV through risky behaviours and 43.6% endorsed a right to refuse providing care. Knowledge and stigma were inversely but weakly correlated (r = −0.17, p<0.001), and higher knowledge was independently associated with lower stigma on multivariable regression (B=−0.16, p<0.001). Despite higher knowledge, males reported significantly higher stigma (B=0.25, p<0.001) compared with their female counterparts. Similarly, participants who completed the Arabic form had significantly lower knowledge and higher stigma (B=0.24, p<0.001).ConclusionsHIV stigma is prevalent among medical students in Egypt, with significant variations observed across gender, survey language and levels of HIV knowledge. These findings call for multifaceted interventions and curriculum reform to reduce stigma among future clinicians. STRENGTHS AND LIMITATIONS OF THIS STUDY The study surveyed a large nationwide sample of medical students representing diverse university sectors (public, private and Al-Azhar), academic years and geographic regions across Egypt. The study surveyed a large nationwide sample of medical students representing diverse university sectors (public, private and Al-Azhar), academic years and geographic regions across Egypt. Data were collected using validated, culturally adapted and pilot-tested instruments (HIV Knowledge Questionnaire-18 and Healthcare Providers HIV/AIDS Stigma Scale) in both Arabic and English. Data were collected using validated, culturally adapted and pilot-tested instruments (HIV Knowledge Questionnaire-18 and Healthcare Providers HIV/AIDS Stigma Scale) in both Arabic and English. Recruitment relied on online convenience sampling and self-reported responses, which may introduce selection, recall and social desirability biases and limit generalisability. Recruitment relied on online convenience sampling and self-reported responses, which may introduce selection, recall and social desirability biases and limit generalisability. The cross-sectional design precludes causal inference regarding the relationship between HIV knowledge, stigma and associated factors. The cross-sectional design precludes causal inference regarding the relationship between HIV knowledge, stigma and associated factors. Introduction HIV and its long-term consequence, AIDS, continue to pose a significant challenge to global public health, with nearly 41 million individuals living with HIV globally in 2025 and over 44 million AIDS-related deaths since the beginning of the epidemic.1 In the Middle East and North Africa region, Egypt has one of the highest numbers of people living with HIV (PLHIV), with an estimated average of 56 000 people living with the virus.2 Unfortunately, the documented number of HIV cases in Egypt is likely an underestimate due to the social stigma surrounding the disease.3 The concept of stigma has had many interpretations throughout the years. Most famously, the 20th-century sociologist Goffman defined it as ‘an attribute that associates a person with an unfavourable stereotype’,4 which leads to the discounting of the person’s value. Likewise, social psychologist Allport described prejudice, a consequence of stigma, as a negative attitude toward someone solely because they belong to a particular group and are assumed to share its perceived undesirable traits.5 Together, their work highlights how stigma and prejudice shape the experiences of marginalised communities, laying the groundwork for understanding the discrimination faced by people with chronic or incurable illnesses.6 People living with chronic or incurable conditions often experience stigma that manifests as discrimination and social exclusion. HIV-related stigma is especially severe since the disease has historically been used to instil fear in the public, fuelling alienation of those affected.7 This stigma is often reinforced by stereotypes associating HIV with socially disapproved behaviours, such as sexual orientation, sexual practices or drug use. The fear of transmission exacerbates the social isolation and alienation directed towards PLHIV since it is the most pressing concern while interacting with them.8 Stigma towards PLHIV can, unfortunately, also be further perpetuated by healthcare providers who have a negative view of the affected communities, reinforcing public bias and further alienating those affected.9 In a study across 64 low- and middle-income countries, nearly half of respondents reported stigmatising or discriminatory attitudes towards PLHIV.10 The ostracisation directed at these communities manifests as social isolation, verbal and physical abuse and a general decrease in the quality of life.11 Furthermore, stigma towards PLHIV affects society as a whole. The fear of being identified as a person with HIV may deter individuals from seeking treatment and proper care or even the ability to stick to the treatment regimen prescribed. This, in turn, further exacerbates negative health outcomes, increasing morbidity, mortality and community viral load.12 13 Lamentably, studies in Egypt have repeatedly shown that stigma towards PLHIV extends to healthcare settings. A study at the HIV unit in Alexandria Hospital reported high levels of stigma towards PLHIV, with particularly negative attitudes from men.14 Similarly, Asaad et al reported strongly discriminatory attitudes among healthcare providers in tertiary hospitals in Zagazig, many of whom advocated for additional precautions when treating patients with HIV.15 Furthermore, in a study of physicians and nurses across 10 governorates in Egypt, Aziz et al found that nearly half of healthcare providers may refuse to treat patients with HIV, even when using protective equipment.16 The stigma towards PLHIV can begin to manifest as early as during medical school, as shown in multiple studies assessing the knowledge and attitudes of medical students in neighbouring Arab countries. Across these studies, a consistent finding was that misinformation about virus transmission contributed to the majority of misconceptions. As shown by Al Bahari et al in his Omani cohort, nearly three-quarters of respondents (73%) incorrectly believed HIV could be transmitted by sharing food, and about one in four (26%) thought casual coughing or sneezing could spread HIV.17 In another Omani cohort, misconceptions about transmission were prominent, as more than a third of the students (39%) believed HIV to be transmissible via insect bites.18 Meanwhile, in the Saudi cohort, four out of five medical students (81%) stated that they would not visit a friend with HIV’s home due to a fear of transmission.19 Despite the widespread HIV stigma in Egypt and the multiple studies conducted among medical students in neighbouring countries, no published study has systematically assessed HIV-related knowledge and stigma among medical students in Egypt. It remains unclear whether the stigmatising attitudes observed among practising healthcare professionals stem from gaps in knowledge or inadequate curriculum coverage during their foundational medical training. Furthermore, most existing studies in the region rely on non-validated tools that fail to capture the multifaceted nature of stigma in this population. Therefore, using validated and appropriate measures, this study aims to evaluate the knowledge and attitudes of Egyptian medical students toward HIV, assess their perceptions of their formal HIV education and identify factors associated with stigma. Methods Study design and setting This was a national, multicentre cross-sectional study with an analytical component conducted in Egypt over 3 weeks in August 2025. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines for reporting observational studies20; a completed STROBE checklist detailing our adherence to each reporting item is provided as a online supplemental file 1. Data were collected from 47 of the 50 faculties of medicine in Egypt, collectively enrolling 152 755 students. The three non-participating faculties were newly established private colleges located in the frontier governorates. Participating faculties represented all major regions of Egypt (lower Egypt, upper Egypt, urban governorates and frontier governorates) and included public, private and Al-Azhar universities, ensuring both geographic and institutional coverage. Public universities, which are the main government-run providers of medical education in Egypt, enrol approximately 70% of students and are tuition-free, as are Al-Azhar universities, which account for 6.5% of medical students. In contrast, private universities are fee-paying institutions and enrol 23.4% of students.21 The medical curriculum in these institutions follows a 5+2 model. The 5-year academic programme is broadly divided into a pre-clinical phase, which adopts an integrated system-based approach with early clinical exposure and a clinical phase consisting of clerkships in major medical specialties. Notably, Al-Azhar faculties operate under a distinct curriculum framework, including separate male and female faculties and additional religious coursework alongside medical education. Patient and public involvement This research did not involve patients or members of the public in setting research questions, designing the study, selecting outcomes, conducting research or planning dissemination. As this study focused on medical students, patient and public involvement was not considered appropriate. Population The study population included first- through fifth-year undergraduate medical students. Eligible participants were currently enrolled medical students in these academic years who provided informed consent to participate. Interns were excluded because their training structure and clinical exposure differ substantially from those of enrolled undergraduate students. Students who did not provide informed consent were also excluded. Participation was voluntary and anonymous and students could complete the questionnaire freely. A total of 1550 students participated in the survey; 47 declined participation consent, resulting in 1503 responses included in the final analysis. Data collection We used a convenience sampling technique due to the logistical difficulties involved in reaching all medical students for probability-based random sampling. Data were collected using an anonymous, self-administered online questionnaire hosted on Google Forms. The survey link was accessible through smartphones, tablets or laptops and could be completed remotely without in-person contact with the research team. Online administration was also chosen to reduce potential social desirability bias that may have resulted from in-person data collection. Thirty-seven student collaborators from participating medical faculties across Egypt were recruited to disseminate the questionnaire among their peers. Collaborators were selected to broadly reflect the underlying distribution of the target population across geographic regions, institution types and academic years, with greater representation from public faculties in accordance with their larger student populations. Collaborators were medical students from the first through fifth academic years; 54% were male. They represented public, private and Al-Azhar institutions across lower Egypt, upper Egypt, urban and frontier governorates. Collaborators received standardised training on survey dissemination and were instructed not to mention HIV or stigma when introducing the study to minimise priming and social desirability bias. Participants were informed that participation was voluntary and anonymous and that no identifying information would be collected. Prior to official data collection, a pilot study was conducted with 30 medical students to evaluate the clarity and suitability of the survey instruments before widespread distribution and to determine the SD of the Healthcare Providers HIV/AIDS Stigma Scale (HPASS) for sample size calculation. Pilot study data were excluded from the final analysis. Based on the feedback received, several revisions were incorporated into the final survey. Data were collected over 3 weeks in August 2025 and were timed to coincide with the end of the academic year for all cohorts to assess students’ knowledge and attitudes following completion of that year’s curriculum, with the exception of fifth-year students who were still undergoing exams during the data collection period. Sample size calculation The required sample size for this study was calculated using the samplingbook package22 in R programming software.23 Using an SD of 16.1 for the HPASS based on the results of the pilot study, a 95% confidence level and a margin of error of 1, the required sample size was calculated as 990. A design effect of 1.5 was applied to account for convenience sampling, yielding a final target sample size of 1485. A total of 1503 responses were ultimately included in the analysis. Measures Data were collected using a bilingual (Arabic/English) online questionnaire. At the start, participants had the choice of selecting their preferred language, and the entire questionnaire was then presented in that language. Participants completed the questionnaire at their own time and pace and without compensation. Anonymity was guaranteed in the beginning of the survey in an attempt to minimise potential social desirability bias. The first section obtained participants’ informed consent, ensuring participants were fully informed about the study’s purpose and willingly agreed to take part before proceeding to the subsequent sections. Participants’ HIV knowledge was assessed using either the original Brief HIV Knowledge Questionnaire (HIV-KQ-18)24 or its validated Arabic version,25 depending on the participant’s language selection. This validated 18-item scale assesses knowledge of HIV/AIDS transmission and prevention, with response options of ‘true’, ‘false’ or ‘don’t know’. Correct answers are scored as 1, whereas incorrect or ‘don’t know’ answers are scored as 0, yielding a total score ranging from 0 to 18. Five items (1, 4, 11, 14 and 17) are true, whereas the other 13 are false. The HIV-KQ-18 has shown excellent reliability, with Cronbach’s alpha ranging from 0.75 to 0.89.24 Participants’ HIV stigma was measured using the HPASS. The original English version of the HPASS consists of 30 items and was developed by Wagner et al to assess HIV stigma among students enrolled in medical careers.11 For this study, we used the 18-item, three-factor structure identified during the scale’s cross-cultural adaptation and validation in an Egyptian context.26 The 18 items of this version were used for both the Arabic and English versions of our survey to ensure consistency across participants. The scale’s 18 items are divided into three subscales: prejudice (assessed by 7 items), stereotypes (assessed by 5 items) and discrimination (assessed by 6 items). Responses are recorded on a 6-point Likert scale ranging from 1 (strongly disagree) to 6 (strongly agree), where higher scores indicate greater stigmatising attitudes. The 18-item version of the HPASS has demonstrated good reliability, with a Cronbach’s alpha of 0.90 in the adaptation and validation study.26 Lastly, we collected anonymised sociodemographic data, including age, sex, nationality and academic year. Participants were also asked if they personally knew someone with HIV and if they had studied HIV/AIDS in their faculty’s curriculum. For participants who affirmed they had studied HIV in their curriculum, a subsection assessed the perceived adequacy of coverage for nine topics, including basic science, modes of transmission, patient communication and stigma. Responses were recorded on a 3-point scale (‘Adequately covered’, ‘Somewhat covered’, ‘Inadequately covered’). Following the pilot study, modifications were made to improve clarity and cultural appropriateness based on participant feedback. Several items in the HIV-KQ-18 were considered slightly inappropriate given the conservative cultural context in Egypt. Accordingly, ‘sex’ was replaced with ‘sexual intercourse’, ‘anal sex’ with ‘anal intercourse’ and ‘period’ with ‘menstrual period’. The term ‘oral sex’ was changed to ‘oral–genital intercourse’. These changes are consistent with the recommendations of Terra et al,25 who translated the HIV-KQ-18 into Arabic and suggested replacing ‘penis’ with ‘male genital organ’ to make the language less explicit and more culturally acceptable in Arab settings. Following these modifications, the scale’s reliability was assessed by calculating Cronbach’s alpha. The scale yielded a Cronbach’s alpha of 0.826, which confirmed that the changes did not negatively affect the internal consistency of the instrument and that its reliability remained consistent with the original version. Several items of the HPASS were also slightly adjusted based on the feedback of the pilot study. For example, ‘HIV +’ was changed to 'HIV positive' to improve readability. Further, a significant modification was made to the term used to describe PLHIV. The validated Arabic version of the HPASS translated ‘HIV positive’ as ‘AIDS patients’. However, as this translation was not justified in the validation study and the terms ‘HIV’ and ‘AIDS’ have distinct clinical and social interpretations for a medical student population, we reverted the term back to ‘HIV positive’ in the Arabic version of the survey to maintain consistency and accuracy. Participants also noted that the terms ‘risky behaviour’ (item 8) and ‘risky activities’ (item 9) were somewhat vague; these were clarified to specify that ‘risky behaviour’ refers to actions such as sexual activity or drug use, consistent with the original scales from which the items were adapted.27 28 In item 11, ‘should accept responsibility’ was clarified as ‘blame or fault for becoming infected’, again following the original scale wording. Additionally, a brief explanation of ‘legal liability’ was added to item 17. After these modifications, the HPASS demonstrated good internal consistency in our sample (overall Cronbach’s α=0.894; prejudice α=0.808; stereotype α=0.822; discrimination α=0.863). To reduce response fatigue and social-desirability bias, the questionnaire order was arranged so that the HPASS (the most sensitive scale) appeared early and sociodemographic items were placed at the end. Placing the stigma scale first encouraged honest attitudinal responses before participants considered personal identifiers. Further, the HIV-KQ-18 was intentionally positioned after the stigma items to avoid participants modifying stigma responses based on their perceived knowledge. Within sections, item order was randomised to minimise systematic fatigue or order effects. At the end of the survey, participants were offered the correct answers to the HIV-KQ-18 with brief explanations for any items they answered incorrectly. Statistical analysis Statistical analysis was conducted using Jamovi statistical software. Continuous variables were summarised as means and SD, as they were found to be normally distributed via visual inspection of Quantile-Quantile plots. Categorical variables were reported as frequencies and percentages. For reporting item-level frequencies on the HPASS, responses on the 6-point scale were collapsed into two categories: 'Disagree’ (responses 1–3) and 'Agree’ (responses 4–6). To assess group differences, mean HIV knowledge and stigma scores were compared across sociodemographic groups using independent samples t-tests for binary variables and one-way analysis of variance (ANOVA) for variables with more than two groups. Tukey’s post hoc test was used to further analyse significant differences in ANOVA. Correlations between variables were examined using a Pearson correlation coefficient, and a multivariable linear regression model was constructed to identify factors independently associated with HIV stigma. A p-value of <0.05 was considered statistically significant for all tests. Participants with incomplete responses in the curriculum adequacy subsection were excluded from that specific analysis. Results Participant characteristics and curriculum experience The total number of participants was 1503, 57.4% of whom were females, with an overall mean age of 20.6 (SD=1.7) and a mean age of 20.4 for females and 20.9 for males. Participants were distributed nearly equally across academic years (20.2%–26.9%), with the exception of fifth years, who comprised only 9.5%. The majority of participants were from public universities (57.5%) and had studied HIV in their curriculum (73.1%) (table 1). Table 1Participants’ sociodemographic characteristics and their association with HIV knowledge and stigma scores (N=1503)CharacteristicsSubgroupFrequency (n (%))HIV knowledge score (mean±SD)*P valueTotal stigma score (mean±SD)†P valueOverall15038.96 (4.26)60.1 (17.6)SexFemale863 (57.4)8.56±4.13 <0.001 58.47±17.52 <0.001 Male640 (42.6)9.50±4.3762.39±17.41NationalityEgyptian1314 (87.4)8.92±4.270.34660.24±17.400.561Non-Egyptian189 (12.6)9.23±4.2059.44±18.74Academic yearFirst year405 (26.9)7.47±4.30 <0.001 60.98±17.740.549Second year347 (23.1)8.53 ± 4.25‡59.87±16.80Third year305 (20.3)9.34 ± 3.90‡60.59±17.04Fourth year303 (20.2)10.15±4.10‡ §,59.78±18.57Fifth year143 (9.5)10.89±3.61‡ §¶58.17±17.93University typePublic864 (57.5)9.32±4.01 <0.001 58.96±17.62 0.002 Private375 (25.0)8.39±4.61**60.71±17.73Azhar264 (17.6)8.58±4.41**63.18±16.85††University regionLower Egypt626 (41.7)8.74±4.200.0859.29±17.650.469Urban533 (35.5)9.09±4.3560.84±17.29Upper Egypt242 (16.1)9.44±3.9460.63±17.44Frontier102 (6.8)8.47±4.7860.45±18.87Acquaintance with HIV+personNo1429 (95.1)8.97±4.230.84460.18±17.600.647Yes74 (4.9)8.86±4.7759.22±17.22Studied HIV in curriculumYes1098 (73.1)9.66±4.00 <0.001 60.17±17.310.909No405 (26.9)7.07±4.3760.05±18.30Form languageArabic980 (65.2)8.14±4.14 <0.001 62.25±16.98 <0.001 English523 (34.8)10.50±4.0556.20±17.99Bold values indicate statistical significance at the p < .05 level.*Possible range: 0–18.†Possible range: 18–108.‡Significantly higher than the first year.§Significantly higher than the second year.¶Significantly higher than the third year.**Significantly less than public.††Significantly higher than public. Participants’ sociodemographic characteristics and their association with HIV knowledge and stigma scores (N=1503) Bold values indicate statistical significance at the p < .05 level. Possible range: 0–18. Possible range: 18–108. Significantly higher than the first year. Significantly higher than the second year. Significantly higher than the third year. Significantly less than public. Significantly higher than public. Among the students who had received formal HIV education and completed this survey subsection (n=1079), scientific topics like virology and modes of transmission were deemed adequately covered by a majority (55.2%). However, nearly half of the participants reported that psychological and ethical topics, such as stigma and discrimination, rights and confidentiality and stereotyping and bias, were inadequately covered (table 2). Table 2Perceived adequacy of HIV/AIDS curriculum coverage among medical students in Egypt (n=1079 reported studying HIV in curricula)Curriculum aspectAdequately covered (n (%))Somewhat covered (n (%))Inadequately covered (n (%))Scientific foundations Modes of transmission596 (55.2%)398 (36.9%)85 (7.9%) Basic science (virology, immunology)584 (54.1%)405 (37.5%)90 (8.3%)Clinical practice Diagnosis and testing470 (43.6%)421 (39.0%)188 (17.4%) Treatment and management410 (38.0%)423 (39.2%)246 (22.8%)Psychosocial and ethical aspects Social and public health impact260 (24.1%)384 (35.6%)435 (40.3%) Rights and confidentiality of PLHIV218 (20.2%)331 (30.7%)530 (49.1%) Stigma and discrimination211 (19.6%)340 (31.5%)528 (48.9%) Patient communication and counselling209 (19.4%)386 (35.8%)484 (44.9%) Stereotyping and bias209 (19.4%)330 (30.6%)540 (50.0%)Note: While 1,098 participants reported studying HIV in their curriculum, 19 incomplete responses for this specific subsection were excluded via list-wise deletion.PLHIV, people living with HIV. Perceived adequacy of HIV/AIDS curriculum coverage among medical students in Egypt (n=1079 reported studying HIV in curricula) Note: While 1,098 participants reported studying HIV in their curriculum, 19 incomplete responses for this specific subsection were excluded via list-wise deletion. PLHIV, people living with HIV. HIV knowledge Table 3 summarises participants’ responses to the HIV-KQ-18. The most correctly answered item was that multiple sexual partners increase HIV risk (90.5%), while the most incorrectly answered was the belief that natural skin condoms are more protective than latex (17.7%). Most students identified common transmission routes such as coughing (61.6%) and sharing a water glass (65.5%), but only 45.7% recognised the risk of oral sexual transmission. Knowledge of prevention and risk factors was mixed: about half knew HIV can be transmitted during menstruation (50.2%), while only a third knew that female condoms are protective (34.7%). For investigations and treatment, most understood antibiotics cannot prevent HIV (74.1%), but only half were aware that no vaccine exists (51.3%). Table 3Frequency and percentage of responses to the HIV-KQ-18 items among medical students in Egypt (n=1503)Knowledge itemCorrect N (%)Coughing and sneezing do not spread HIV. (True)926 (61.6%)A person can get HIV by sharing a glass of water with someone who has HIV. (False)984 (65.5%)Pulling out the penis before a man climaxes/cums keeps a woman from getting HIV during sex. (False)674 (44.8%)A woman can get HIV if she has anal sex with a man. (True)817 (54.4%)Showering or washing one’s genitals/private parts, after sex keeps a person from getting HIV. (False)796 (53.0%)All pregnant women infected with HIV will have babies born with AIDS. (False)620 (41.3%)People who have been infected with HIV quickly show serious signs of being infected. (False)987 (65.7%)There is a vaccine that can stop adults from getting HIV. (False)771 (51.3%)People are likely to get HIV by deep kissing, putting their tongue in their partner’s mouth, if their partner has HIV. (False)600 (39.9%)A woman cannot get HIV if she has sex during her period. (False)755 (50.2%)There is a female condom that can help decrease a woman’s chance of getting HIV. (True)522 (34.7%)A natural skin condom works better against HIV than does a latex condom. (False)266 (17.7%)A person will not get HIV if she or he is taking antibiotics. (False)1114 (74.1%)Having sex with more than one partner can increase a person’s chance of being infected with HIV. (True)1360 (90.5%)Taking a test for HIV 1 week after having sex will tell a person if she or he has HIV. (False)448 (29.8%)A person can get HIV by sitting in a hot tub or a swimming pool with a person who has HIV. (False)700 (46.6%)A person can get HIV from oral sex. (True)687 (45.7%)Using Vaseline or baby oil with condoms lowers the chance of getting HIV. (False)440 (29.3%)HIV-KQ-18, HIV Knowledge Questionnaire. Frequency and percentage of responses to the HIV-KQ-18 items among medical students in Egypt (n=1503) HIV-KQ-18, HIV Knowledge Questionnaire. HIV stigma Table 4 presents participants’ responses to the HPASS. Most participants (76.8%) worried about contracting HIV from patients with HIV+, and 65.5% were concerned about the inadequate general protective measures. Due to personal fear of contamination, avoiding certain procedures on patients with HIV+ was predominant in 44.8%, and nearly half (43.6%) even believed in the right to refuse providing treatment for fear of transmission. Over half of the participants (52%) believed that patients with HIV+ were infected through risky behaviours, despite knowing the risks (50.7%), while a third (32.5%) agreed that patients with HIV+ would not have acquired the virus had they not had multiple sexual partners. Table 4Responses to the HPASS among medical students in Egypt (n=1503)ItemMean (SD)Agree N (%)Disagree N (%)Prejudice25.2 (7.84) I worry about contracting HIV from patients with HIV+.4.50 (1.53)1154 (76.8%)349 (23.2%)Patients with HIV+ make me uncomfortable.3.26 (1.64)670 (44.6%)833 (55.4%)I would be hesitant to send patients with HIV+ for blood work due to concern for others’ safety.3.19 (1.68)610 (40.6%)893 (59.4%)It is a little scary to think I have touched patients with HIV+.3.43 (1.76)755 (50.2%)748 (49.8%)I worry that general protective measures are not good enough to protect me.4.12 (1.58)984 (65.5%)519 (34.5%)I would feel uncomfortable knowing one of my colleagues is HIV+.3.63 (1.69)837 (55.7%)666 (44.3%)It would be hard to react calmly if a patient tells me they are HIV+.3.10 (1.61)618 (41.1%)885 (58.9%)Stereotype15.3 (6.09) I believe most patients with HIV+ were infected through risky behaviour.3.47 (1.63)781 (52.0%)722 (48.0%)I think patients with HIV+ have engaged in risky activities despite knowing the risks.3.41 (1.55)762 (50.7%)741 (49.3%)I think people would not get HIV if they did not have multiple sexual partners.2.72 (1.67)488 (32.5%)1015 (67.5%)Patients with HIV+ tend to have numerous sexual partners.3.12 (1.57)613 (40.8%)890 (59.2%)Patients with HIV+ should accept responsibility for acquiring the virus.2.61 (1.53)419 (27.9%)1084 (72.1%)Discrimination19.6 (7.68) I believe I have the right to refuse treatment for the safety of other patients.3.05 (1.64)588 (39.1%)915 (60.9%)I believe I have the right to refuse treatment if other staff are concerned about safety.3.18 (1.62)631 (42.0%)872 (58.0%)I would avoid conducting certain medical procedures on patients with HIV+.3.22 (1.65)673 (44.8%)830 (55.2%)I believe I have the right to refuse treatment if I feel uncomfortable.3.26 (1.70)671 (44.6%)832 (55.4%)I believe I have the right to refuse treatment to protect myself.3.22 (1.70)655 (43.6%)848 (56.4%)I believe I have the right to refuse treatment if I am concerned about legal liability.3.64 (1.66)837 (55.7%)666 (44.3%)Total stigma60.1 (17.6)Items were rated on a 6-point Likert scale (1=strongly disagree, 6=strongly agree). For frequency reporting, 'Disagree’ combines responses 1–3 and 'Agree’ combines responses 4–6.Possible score ranges are the following: prejudice (7-42), stereotype (5-30), discrimination (6-36) and total stigma (18-108). Responses to the HPASS among medical students in Egypt (n=1503) Items were rated on a 6-point Likert scale (1=strongly disagree, 6=strongly agree). For frequency reporting, 'Disagree’ combines responses 1–3 and 'Agree’ combines responses 4–6. Possible score ranges are the following: prejudice (7-42), stereotype (5-30), discrimination (6-36) and total stigma (18-108). Differences in HIV knowledge and stigma The mean HIV knowledge score was 8.96 (SD=4.26) out of a possible 18, while the mean total stigma score was 60.1 (SD=17.6) on a scale of 18–108. Male participants reported significantly higher stigma (62.39 vs 58.47, p<0.001) despite having higher knowledge (9.50 vs 8.56, p<0.001) when compared with their female counterparts. The level of knowledge, expectedly, increased steadily from the first year (7.47, p<0.001) to the fifth year (10.89, p<0.001), while there were no significant differences in stigma levels. Regarding survey language, participants who completed the questionnaire in Arabic reported lower knowledge (8.14 vs 10.50, p<0.001) and higher stigma (62.25 vs 56.20, p<0.001). Students who reported curricular exposure to HIV demonstrated significantly higher knowledge than those without such exposure (9.66 vs 7.07, p<0.001). However, stigma scores did not differ significantly by curricular exposure (table 1). Factors associated with HIV stigma Table 5 presents the bivariate correlations between independent variables and total stigma scores, while Table 6 presents the final multivariable regression model identifying the factors independently associated with stigma. Table 5Pearson’s correlation matrix for HIV knowledge and stigma scores among medical students in EgyptVariable12345Knowledge—Total stigma −0.170 —Discrimination −0.107 0.833 —Stereotype −0.111 0.700 0.334 —Prejudice −0.191 0.881 0.628 0.464 —All correlations are statistically significant at p<0.001.Bold values indicate statistical significance at the p < .05 level. Pearson’s correlation matrix for HIV knowledge and stigma scores among medical students in Egypt All correlations are statistically significant at p<0.001. Bold values indicate statistical significance at the p < .05 level. Table 6Multivariable regression analysis of factors associated with HIV stigma scores among medical students in EgyptVariableStandardised estimate (β)(95% CI)P valueAge−0.01(-0.09 to 0.07)0.794Sex (ref: female) Male0.25(0.15 to 0.36) <0.001 Academic year (ref: first year) Second year−0.05(-0.21 to 0.10)0.487 Third year0.01(-0.17 to 0.19)0.932 Fourth year0.02(-0.20 to 0.23)0.889 Fifth year−0.02(-0.31 to 0.26)0.862Nationality (ref: Egyptian) Non-Egyptian−0.10(-0.26 to 0.07)0.251University region (ref: lower Egypt) Frontier0.04(-0.19 to 0.27)0.722 Upper0.09(-0.06 to 0.24)0.24 Urban0.07(-0.07 to 0.22)0.309University type (ref: public) Azhar0.08(-0.10 to 0.25)0.386 Private0.03(-0.12 to 0.18)0.7Acquaintance with patients with HIV+ (ref: no) Yes−0.09(-0.32 to 0.14)0.464Studied HIV in curriculum (ref: no) Yes0.10(-0.03 to 0.23)0.148Form language (ref: Arabic) English−0.24(-0.13 to -0.35) <0.001 Knowledge score−0.16(-0.22 to −0.11) <0.001 Bold values indicate statistical significance at the p < .05 level. Multivariable regression analysis of factors associated with HIV stigma scores among medical students in Egypt Bold values indicate statistical significance at the p < .05 level. HIV knowledge was significantly and negatively correlated with total stigma (r=−0.170, p<0.001), and this relationship remained significant in the multivariable model (B=−0.16, p<0.001). Similarly, both being male and choosing the Arabic language form were significant factors in the final regression model (B=0.25, p<0.001 and B=−0.24, p<0.001, respectively). Conversely, attending Al-Azhar universities did not retain significance in the multivariable regression model (B=0.08, p=0.386). Discussion HIV stigma is widespread in Egypt, extending even into healthcare settings. It remains a major obstacle to controlling the epidemic and warrants urgent investigation. Our findings indicate that, despite being the country’s future physicians, participants demonstrated only moderate knowledge alongside pervasive stigmatising attitudes. The curriculum on the psychosocial dimensions of HIV care was also deemed largely inadequate. Stigmatising attitudes were characterised predominantly by fear of contagion and assumptions that HIV was acquired through risky sexual behaviours. Although higher knowledge was inversely correlated with stigma, the relationship was weak, suggesting that higher knowledge alone may be insufficient to alleviate stigmatising attitudes among students. Our study revealed substantial knowledge gaps. On average, students correctly answered only 9 of the 18 HIV-KQ-18 items, a concerning result given that this tool was designed to assess the general population rather than healthcare trainees.24 This mirrors the results of a five-country Arab study, where university students answered only half of the HIV-KQ-18 questions correctly.25 Gaps in knowledge of oral and vertical transmission were especially pronounced in our sample, echoing reports from Oman17 and Saudi Arabia,19 where medical students reported similar misconceptions about the possibility of HIV transmission via food sharing and casual contact. By contrast, recognition of sexual transmission, particularly through multiple partners, was relatively high both in our study and that of Terra et al.25 Notably, most knowledge deficits clustered around items related to sexual practices, which aligns with a previous study where only 26% of Egyptian youth reported discussing sexual matters with parents despite 61% supporting sexual education and where misconceptions and negative attitudes toward sexual behaviours were widespread.29 Together, these findings suggest that limited open dialogue and reliance on informal or culturally constrained sources of information may contribute to persistent inaccuracies in sexual health knowledge, even among medical students. In this light, our study found a high prevalence of stigmatising attitudes among participants, primarily regarding fear of contagion and assumptions that PLHIV had acquired the virus through risky sexual behaviour. These findings are consistent with recent studies of Egyptian healthcare workers and appear to be rooted in local cultural norms, which are further reinforced by the way HIV is represented in Egyptian media. Sharaf’s analysis of Egyptian dramas found that HIV is almost exclusively depicted as the result of illicit sexual relationships, while accurate information on transmission and prevention is largely absent.30 This portrayal may explain nearly why half of our participants associated HIV with risky behaviours and worried about contracting HIV from patients, closely mirroring the findings of Aziz et al,16 where over 75% of physicians and nurses expressed the same fear. Further, Sharaf also noted media depictions of surgeons refusing to operate on PLHIV,30 paralleling our finding of nearly half of students endorsing refusing care and echoing reports from studies across 11 Egyptian governorates where many providers admitted they might decline to treat such patients.15 16 Collectively, these portrayals not only reinforce stigma but also leave key gaps in accurate knowledge, making it important to consider how knowledge and attitudes intersect in relation to students’ perceptions of HIV. Building on this, we found a significant, although weak, association between HIV knowledge and stigma. This is consistent with a similar study among medical students in Jordan that found that limited knowledge was associated with more stigmatising attitudes toward PLHIV.31 This relationship is not limited to medical student populations, as a systematic review and meta-analysis of 40 studies across diverse populations reported that greater HIV knowledge was significantly associated with less stigma, though the magnitude of the association was modest.32 Yet, this relationship is not universal. For example, a study in Iran found no difference in stigma levels between medical and non-medical students despite the former’s presumed higher knowledge,33 while research in Nepal likewise showed no significant link between knowledge and stigma among healthcare providers.34 Taken together, these findings further suggest that knowledge alone does not fully explain attitudes toward PLHIV and that other personal and sociocultural factors also likely play a role. One such personal factor associated with stigma is gender. In our study, male students reported significantly higher levels of HIV-related stigma compared with females, a finding consistent with that of other studies among medical students in Croatia35 and Tuzla.36 However, this relationship does not appear to be universal. For instance, studies among university students in the United Arab Emirates37 and Fiji38 found no significant gender differences in HIV-related stigma, while research among healthcare providers in Sudan39 and Malaysia40 even reported greater discriminatory intent among females. In Egypt, however, the evidence consistently points toward higher stigma among men. For example, ElSayed et al41 found that male nursing students displayed more negative attitudes toward PLHIV,41 while Zoromba et al reported that male medical students expressed significantly greater stigma toward another chronic illness, breast cancer.42 Similarly, Magdy et al also reported that male healthcare providers at the HIV unit of Alexandria Hospital held markedly more negative views toward PLHIV,14 a pattern further supported by national surveys where male gender was identified as a significant predictor of higher stereotype scores.16 26 The underlying reasons for these gender differences are likely rooted in Egypt’s complex sociocultural context, where HIV is heavily moralised and associated with fears of ‘immoral’ sexual behaviour.3 Media narratives that depict HIV as a consequence of illicit sexual activity likely further reinforce these norms.30 Another relevant sociocultural factor is survey language. In our study, participants who completed the survey in Arabic exhibited significantly higher stigma scores, even after adjusting for knowledge. This may reflect the role of language in transmitting cultural values and shared social norms.43 44 Respondents using Arabic may reflect closer alignment with traditional cultural norms, societal taboos and moral frameworks related to PLHIV, and Arabic terminology itself may carry stronger stigma-laden emotional or moral connotations. Together, these findings suggest that gender and language may act as channels through which deeply ingrained cultural norms shape stigmatising attitudes. Further global systematic reviews of stigma-reduction interventions report mixed outcomes: some programmes achieved meaningful reductions, while others saw little change even when knowledge improved. These findings suggest that stigma is not merely the result of misinformation but is reinforced by deeper cultural and moral narratives, as highlighted in our earlier discussion of Egyptian media portrayals. Interventions that focus solely on correcting factual gaps may fall short unless they also address the social and cultural frameworks that sustain stigma. Collectively, our findings of the weak association between HIV knowledge and stigma alongside the potential influence of cultural norms underscore the need for comprehensive and contextually tailored strategies to reduce HIV-related stigma among medical students in Egypt. First, medical curricula should be strengthened to address both factual knowledge gaps and the psychosocial and ethical dimensions of HIV, which participants perceived as insufficient. Integrating modules that explicitly tackle stigma and cultural misconceptions, such as the UNAIDS ethics module, can help students develop more empathetic and non-judgmental attitudes. Second, given that systematic reviews of stigma-reduction programmes report mixed outcomes,45 targeted interventions should be customised to the local setting, context and culture, as recommended by our findings as well as Mohammadifirouzeh et al in their review of interventions for healthcare providers and students.46 Practical strategies may include student-centred learning approaches, such as peer education and simulations, as peer educators act as credible role models who can simultaneously shift group norms.46 47 Third, interventions, curricula and educational campaigns should be culturally inclusive and delivered in Arabic when appropriate to engage those most influenced by traditional norms and maximise participation. By combining knowledge enhancement with culturally sensitive, context-specific strategies and hands-on experiential interventions, medical education can more effectively challenge deeply rooted beliefs, reduce fear-driven discrimination and promote equitable care for PLHIV. Limitations This study has several limitations. First, its cross-sectional design precludes causal inference; future longitudinal studies are needed to clarify the causal relationships between knowledge and stigma. Although we attempted to reflect the national distribution of medical students, recruitment ultimately relied on convenience sampling, which may introduce selection bias and limit the generalisability of our findings to all Egyptian medical students. Further, the comparatively small proportion of fifth-year students due to the timing of data collection during exam season may weaken statistical representation of that cohort. Third, the reliance on self-report measures is susceptible to social desirability and recall biases, which may have influenced responses. Additionally, potentially relevant factors such as religious background, media exposure and family socioeconomic status were not measured, and residual confounding from these and other unmeasured factors cannot be excluded. Finally, while we used validated instruments, translation nuances may have affected item interpretation across language forms, and the potential for unmeasured confounding from variables not included in our model cannot be excluded; future research should include these variables to better examine the factors associated with stigma. Conclusions In conclusion, despite widespread HIV stigma in Egypt, medical students demonstrated only moderate knowledge and pervasive stigmatising attitudes co-occurring with misconceptions about disease acquisition. While knowledge was negatively associated with stigma, personal factors such as gender and cultural factors, including language, also played a role. Our findings highlight the need to strengthen Egyptian medical curricula, addressing both knowledge gaps and the psychosocial and ethical dimensions of HIV, including stigma. Culturally sensitive, tailored education can better equip the next generation of physicians to provide equitable, high-quality care for PLHIV. Supplementary material